Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial

Nicolino Ruperto, Hermine I Brunner, Olga Synoverska, Tracy V Ting, Carlos Abud Mendoza, Alberto Spindler, Yulia Vyzhga, Katherine Marzan, Lyudmila Grebenkina, Irit Tirosh, Lisa Imundo, Rita Jerath, Daniel J Kingsbury, Betul Sozeri, Sheetal S Vora, Sampath Prahalad, Elena Zholobova, Yonatan Butbul Aviel, Vyacheslav Chasnyk, Melissa Lerman, Kabita Nanda, Heinrike Schmeling, Heather Tory, Yosef Uziel, Diego O Viola, Holly B Posner, Keith S Kanik, Ann Wouters, Cheng Chang, Richard Zhang, Irina Lazariciu, Ming-Ann Hsu, Ricardo M Suehiro, Alberto Martini, Daniel J Lovell, R Cuttica, J Akikusa, J Chaitow, C Wouters, S Oliveira, CLS Neiva, M Santiago, CA Silva, MT Terreri, C Magalhaes, V De Souza, M Bandeira, G Chédeville, K Houghton, M Vazquez-Del Mercado, J Rizo Rodriguez, K Kobusinska, E Alexeeva, I Calvo Penades, AL Boteanu, O Kasapcopur, MH Poyrazoglu, M Erguven, S Ozen, E Al-Abadi, J Bohnsack, R Carrasco, J Dare, B Gottlieb, D Wahezi, L Jung, M Klein-Gitelman, Y Zhang, L Wagner-Weiner, S Tarvin, RK Vehe, P Chiraseveenuprapund, R Rivas-Chacon, W De La Pena, ACP Sagcal-Gironella, JE Weiss